Mohamed et al. showed that serum methylated RASSF1A levels have a predictive value of 72.5% for early diagnosis of HCC, particularly in patients at high risk (those with HCV infection), and recommended periodic evaluation using this non-invasive test in patients with HCV infection [28]. This evidence concerns the gene RASSF1 and hepatocellular carcinoma.